Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B

por Mahlangu, Johnny N.
Publicado 2018

Progress in the Development of Anti-tissue Factor Pathway Inhibitors for Haemophilia Management

por Mahlangu, Johnny N.
Publicado 2021

Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa

por Nalado, Aishatu Mohammed, Mahlangu, Johnny N, Waziri, Bala, Duarte, Raquel, Paget, Graham, Olorunfemi, Gbenga, Naicker, Saraladevi
Publicado 2019

Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa

por Nalado, Aishatu Muhammad, Mahlangu, Johnny N., Duarte, Raquel, Paget, Graham, Olorunfemi, Gbenga, Jacobson, Barry F., Naicker, Saraladevi
Publicado 2018

Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies

por Parnes, Aric, Mahlangu, Johnny N., Pipe, Steven W., Paz‐Priel, Ido, Lehle, Michaela, Trask, Peter C., Jiménez‐Yuste, Víctor
Publicado 2021

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database

por Peyvandi, Flora, Mahlangu, Johnny N., Pipe, Steven W., Hay, Charles R. M., Pierce, Glenn F., Kuebler, Peter, Kruse‐Jarres, Rebecca, Shima, Midori
Publicado 2020

Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis...

por Kempton, Christine, Trask, Peter, Parnes, Aric, Niggli, Markus, Campinha‐Bacote, Avrita, U. Callaghan, Michael, O'Connell, Niamh, Paz‐Priel, Ido, Mahlangu, Johnny N.
Publicado 2021

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies

por Chowdary, Pratima, Holmström, Margareta, Mahlangu, Johnny N., Ozelo, Margaret C., Pabinger, Ingrid, Pasi, K. John, Ragni, Margaret V., Shapiro, Amy, Barnowski, Chris, Lethagen, Stefan
Publicado 2022

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database

por Pipe, Steven W., Kruse‐Jarres, Rebecca, Mahlangu, Johnny N., Pierce, Glenn F., Peyvandi, Flora, Kuebler, Peter, De Ford, Christian, Sanabria, Fabián, Ko, Richard H., Chang, Tiffany, Hay, Charles R. M.
Publicado 2020

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

por Mahlangu, Johnny N., Lamas, Jose Luis, Morales, Juan Cristobal, Malan, Daniel R., Šalek, Silva Zupančić, Wang, Michael, Boggio, Lisa N., Hegemann, Inga, Mital, Andrzej, Cardinal, Matthew, Zhu, Tong, Sun, Pengling, Arkin, Steven
Publicado 2022

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

por van Galen, Karin P. M., d’Oiron, Roseline, James, Paula, Abdul‐Kadir, Rezan, Kouides, Peter A., Kulkarni, Roshni, Mahlangu, Johnny N., Othman, Maha, Peyvandi, Flora, Rotellini, Dawn, Winikoff, Rochelle, Sidonio, Robert F.
Publicado 2021